Formulary Chapter 6: Endocrine system - Full Chapter
06.01.01.02
Intermediate- and long-acting insulins
Insulin glargine preparations are not interchangeable
For new initiations of glargine- use Semglee
Insulatard® (Isophane Insulin )
First Choice
Basal Insulin-First Line
Available as:
Cartridges
Innolet device
Semglee® (Insulin glargine )
Formulary
For new initiations for patients requiring glargine
Available as:
Pre-filled pens
Abasaglar® (Insulin glargine )
Formulary
Basal insulin
Available as:
Cartridges
Kwikpen
Note - within North East Essex CCG, the use of biosimilar glargine Semglee has also been approved for use
Lantus® (Insulin Glargine)
Formulary
Basal insulin
For continuation only
Available as:
Cartridges
Vials
Solostar pre filed pen
Toujeo® (Insulin Glargine )
Formulary
Basal insulin
Available as:
Solostar® pre filled pen
Caution-High strength:300 units/ml - to be used only in patients requiring high doses of insulin therapy; to decrease injection volume load
Levemir® (Insulin Detemir)
Formulary
Basal insulin
Available as:
Cartridges
Flexpen pre-filled pen
Xultophy® (Insulin degludec and liraglutide)
Formulary
Basal insulin with GLP-1 anologue
Tresiba® (Insulin degludec ) (100 units/ml)
Formulary
Basal insulin
Available as:
Cartridges
FlexTouch pre-filled pen
Insulin degludec (Tresiba®) (200 units/ml)
Restricted
Ipswich Hospital
Insulin degludec (Tresiba) 200units/ml is a non-formulary medicine
Colchester Hospital
Insulin degludec (Tresiba) 200units/ml is a formulary medicine - but very restricted use; only for patients requiring high doses of insulin therapy to decrease injection volume load
Isophane insulin (Insuman Comb) is a non-formulary medicine
Colchester Hospital
Isophane insulin (Insuman Comb) is considered a formulary medicine; albeit with very limited usage. Treatment is unlikely to be initiated within the acute hospital.
Caution-High strength:300 units/ml - to be used only in patients requiring high doses of insulin therapy; to decrease injection volume load
Restricted
